Search research articles
Contact Us
Filters
Showing results (1-10 of 153) with videos related to
Page
of 16
Sort By:
Clinical Chemistry
|
July 1, 1975
Modification of a commercially available digoxin radioimmunoassay kit for higher precision
W J van der Vijgh
Clinical Pharmacokinetics
|
October 1, 1991
Clinical pharmacokinetics of carboplatin
W J van der Vijgh
International Journal of Clinical Pharmacology and Biopharmacy
|
June 1, 1977
Pharmacokinetic aspects of digoxin in patients with terminal renal failure. II. On hemodialysis
W J van der Vijgh
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Protein binding of five platinum compounds. Comparison of two ultrafiltration systems
W J van der Vijgh, I Klein
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach
M Treskes, W J van der Vijgh
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1996
Amifostine (Ethyol): pharmacokinetic and pharmacodynamic effects in vivo
W J van der Vijgh, A E Korst
International Journal of Clinical Pharmacology and Biopharmacy
|
November 1, 1978
Pharmacokinetic aspects of digoxin in patients with terminal renal failure. IV. Clinical implications of own observations with a recent review of literature
W J van der Vijgh, P L Oe
International Journal of Clinical Pharmacology and Biopharmacy
|
December 1, 1977
Pharmacokinetic aspects of digoxin in patients with terminal renal failure III. Effect of heparin
W J van der Vijgh, P L Oe
Seminars in Oncology
|
October 1, 1994
Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (Ethyol): preclinical aspects
W J van der Vijgh, G J Peters
European Journal of Clinical Pharmacology
|
December 2, 1977
Double blind study of the effect of glafenine (Glifanan) on oral anticoagulant therapy with phenprocoumon (Marcumar)
J K Boeijinga, W J van der Vijgh
Page
of 16
Search research articles
Search
Showing results (1-10 of 153) with videos related to
Sort By:
Page
of 16
Clinical Chemistry
|
July 1, 1975
Modification of a commercially available digoxin radioimmunoassay kit for higher precision
W J van der Vijgh
Clinical Pharmacokinetics
|
October 1, 1991
Clinical pharmacokinetics of carboplatin
W J van der Vijgh
International Journal of Clinical Pharmacology and Biopharmacy
|
June 1, 1977
Pharmacokinetic aspects of digoxin in patients with terminal renal failure. II. On hemodialysis
W J van der Vijgh
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Protein binding of five platinum compounds. Comparison of two ultrafiltration systems
W J van der Vijgh, I Klein
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach
M Treskes, W J van der Vijgh
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1996
Amifostine (Ethyol): pharmacokinetic and pharmacodynamic effects in vivo
W J van der Vijgh, A E Korst
International Journal of Clinical Pharmacology and Biopharmacy
|
November 1, 1978
Pharmacokinetic aspects of digoxin in patients with terminal renal failure. IV. Clinical implications of own observations with a recent review of literature
W J van der Vijgh, P L Oe
International Journal of Clinical Pharmacology and Biopharmacy
|
December 1, 1977
Pharmacokinetic aspects of digoxin in patients with terminal renal failure III. Effect of heparin
W J van der Vijgh, P L Oe
Seminars in Oncology
|
October 1, 1994
Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (Ethyol): preclinical aspects
W J van der Vijgh, G J Peters
European Journal of Clinical Pharmacology
|
December 2, 1977
Double blind study of the effect of glafenine (Glifanan) on oral anticoagulant therapy with phenprocoumon (Marcumar)
J K Boeijinga, W J van der Vijgh
Page
of 16